Cyclopentoiate en es it fr

Cyclopentoiate Brand names, Cyclopentoiate Analogs

Cyclopentoiate Brand Names Mixture

  • No information avaliable

Cyclopentoiate Chemical_Formula


Cyclopentoiate RX_link

No information avaliable

Cyclopentoiate fda sheet

Cyclopentoiate msds (material safety sheet)

Cyclopentoiate MSDS

Cyclopentoiate Synthesis Reference

No information avaliable

Cyclopentoiate Molecular Weight

291.385 g/mol

Cyclopentoiate Melting Point

139 oC (hydrochloride salt)

Cyclopentoiate H2O Solubility

No information avaliable

Cyclopentoiate State


Cyclopentoiate LogP


Cyclopentoiate Dosage Forms

Ophthalmic solution (eye drops)

Cyclopentoiate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Cyclopentoiate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Cyclopentoiate Absorption

Absorbed following ophthalmic administration.

Cyclopentoiate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Cyclopentoiate Patient Information

No information avaliable

Cyclopentoiate Organisms Affected

Humans and other mammals